Careers in AMMedical

3D Systems’ Medical Advisory Board adds two new doctors

Dr. Toby Cosgrove and Dr. Bon Ku have been appointed to the company's recently established MAB - whose primary mission is to provide strategic input, guidance, and recommendations for the company’s expanding efforts in regenerative medicine

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

3D Systems has appointed Dr. Toby Cosgrove, former president and chief executive officer of the Cleveland Clinic, and Dr. Bon Ku, director of the Health Design Lab at Thomas Jefferson University, as the fourth and fifth members of the company’s recently established Medical Advisory Board (MAB). Dr. Cosgrove and Dr. Ku will join former Health & Human Services Secretary Alex Azar, Dr. Stephen K. Klasko, and former US Secretary of Veterans Affairs David J. Shulkin as members of the advisory board. The Board’s primary mission is to provide strategic input, guidance, and recommendations for the company’s expanding efforts in regenerative medicine.

Dr. Toby Cosgrove has distinguished himself as a leader of one of the world’s most recognized healthcare institutions, a renowned medical practitioner, and as a forward-looking healthcare innovator. Having been affiliated with the Cleveland Clinic healthcare system for nearly 50 years, Dr. Cosgrove served as President and Chief Executive Officer from 2004 to 2017 and is currently an Executive Advisor to the Clinic. As President and CEO, Dr. Cosgrove oversaw a $6 billion annual revenue institution comprised of the Cleveland Clinic, over 20 Ohio-based hospitals, family health centers, and surgical facilities, as well as Cleveland Clinic affiliates in other US states, and internationally. During Dr. Cosgrove’s tenure leading the Cleveland Clinic, the clinic was ranked among the top three hospitals in America by US News and World Report, and he championed a broad range of initiatives to improve clinical outcomes, increase patient satisfaction, and focus the clinic’s delivery of health care services around specific organ systems and diseases.

Before serving as the Cleveland Clinic’s top executive, Dr. Cosgrove was a cardiac surgeon at the clinic and served as Chairman of its Department of Thoracic and Cardiovascular Surgery from 1989 to 2004. He has performed more than 22,000 operations over the course of his career and is widely regarded as a pioneer in the field of advanced surgical techniques. Deeply committed to medical innovation and to applying new technologies for the benefit of patients, Dr. Cosgrove has over 30 patents filed for new medical and clinical products used in surgical environments.

Dr. Toby Cosgrove and Dr. Bon Ku appointed to 3D Systems' Medical Advisory Board - focussed on the company’s efforts in regenerative medicine
Dr. Toby Cosgrove, left, Dr. Bon Ku, right.

Dr. Bon Ku has enjoyed a distinguished career as both a practicing medical clinician and as a visionary proponent of using technology-based innovations to solve pressing healthcare challenges. Dr. Ku is the Marta and Robert Adelson Professor of Medicine and Design at Thomas Jefferson University as well as an emergency physician at the University’s Sidney Kimmel Medical College.

Dr. Ku is widely regarded as an authority on accelerating healthcare innovation through the use of modern technological tools such as virtualization, digital modeling, prototyping, and additive manufacturing. He is the co-founder and Director of Thomas Jefferson University’s Health Design Lab, a unique institution that works with medical students, researchers, and physicians to develop new medical devices and innovative design concepts for the healthcare sector. The Health Design Lab, led by Dr. Ku, features a clinical 3D printing and bioprinting lab and is home to the JeffSolves MedTech initiative, which serves as a center for the incubation and commercialization of new medical technologies. Dr. Ku is also the author of numerous peer-reviewed publications focusing on the application of 3D printed medical devices and digital models to improve surgical outcomes, optimize treatments, and make advancements in personalized medicine.

“We are exceptionally pleased to welcome Dr. Cosgrove and Dr. Ku to our Medical Advisory Board. These two professionals have impeccable track records of combining hands-on medical practice experience with a clear passion for utilizing innovative approaches and modern technology to transform healthcare outcomes. Both Dr. Cosgrove and Dr. Ku will be uniquely positioned to advise 3D Systems as we build a world-class regenerative medicine business and pursue 3D printing-based advancements in areas such as accelerated pharmaceutical development, human tissue and organ printing, medical device innovation, and personalized medicine,” commented Dr. Jeffrey Graves, President, and CEO of 3D Systems, on the appointments of Dr. Cosgrove and Dr. Ku.

Research 2022
Polymer AM Market Opportunities and Trends

This new market study from 3dpbm Research provides an in-depth analysis and forecast of the three core segm...

Edward Wakefield

Edward is a freelance writer and additive manufacturing enthusiast looking to make AM more accessible and understandable.

Related Articles

Back to top button

We use cookies to give you the best online experience and for ads personalisation. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services



Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*